Prostaglandin E2 Suppresses Expansion and Effector Differentiation of Tumor-Infiltrating Stem-like CD8+ T Cells
Tumor-derived prostaglandin E2 (PGE2) restricts the proliferative expansion and effector differentiation of TCF1+ stem-like CD8+ T cells within tumors, promoting cancer immune escape.